Blood thinning before surgery for ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests if removing some blood before surgery and replacing it with fluids can reduce the need for transfusions in people with advanced ovarian cancer. It may help you have less blood loss during your operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have advanced ovarian, fallopian tube, or primary peritoneal cancer (stage IIIC or IV).
- You are scheduled for surgery to remove as much cancer as possible (cytoreductive surgery).
- Your blood count (hemoglobin) is 10 or higher within 45 days before surgery.
- You do not have serious heart, lung, kidney, or blood clotting problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving two commonly used medicines before surgery—one that can lower stress on the body (a beta-blocker) and one that reduces inflammation (a COX-2 inhibitor)—can improve outcomes compared with standard care. It’s for people with advanced ovarian, fallopian tube, or primary peritoneal cancer who are having open surgery.
This study tests a proactive approach to monitoring and managing blood flow during surgery for ovarian cancer, including a heated chemotherapy bath (HIPEC). It aims to improve recovery by keeping your blood pressure and circulation stable.
This study is testing a blood test to see if it can catch ovarian cancer early. You may be eligible if you have been recently diagnosed with ovarian cancer and haven't started treatment yet.
This study is testing a new blood test to help find ovarian cancer early in women who are at average risk. By joining, you may help improve early detection, which could lead to better outcomes.
This study looks at why some people develop blood disorders after cancer treatment. It monitors changes in blood cells to better predict and prevent these problems.
This study tests whether a technique that thins your blood during surgery can help people having bone tumor removal. It may reduce the need for blood transfusions.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.